fda glp-1 warning september 2025 Issues Warnings Against Illegal Marketing FDA Sends Warning Letters to

Ketogenic diets which are low in carbs and high in fats have shown potential benefits in small studies, possibly by lowering oxidative stress and improving energy use in cells

Share your questions

Weekly or biweekly: Athletes, high-performers, and those managing chronic fatigue benefit most from frequent at-home IV therapy sessions

ATTAIN-1 (NCT05869903) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron at various doses to placebo in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes

There are also a similar class of drugs, called tirzepatide, and those include meds Mounjaro (for type 2 diabetes) and Zepbound (for weight loss)

Choudhury H, Gorain B, Karmakar S, Biswas E, Dey G, Barik R, et al